256 related articles for article (PubMed ID: 30016594)
1. Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5).
Kou L; Sun R; Ganapathy V; Yao Q; Chen R
Expert Opin Ther Targets; 2018 Aug; 22(8):715-726. PubMed ID: 30016594
[TBL] [Abstract][Full Text] [Related]
2. Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter-Targeting Nanoparticles: A Case Study of High-Efficiency SLC22A5 (OCTN2)-Mediated Carnitine-Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs.
Kou L; Yao Q; Sun M; Wu C; Wang J; Luo Q; Wang G; Du Y; Fu Q; Wang J; He Z; Ganapathy V; Sun J
Adv Healthc Mater; 2017 Sep; 6(17):. PubMed ID: 28661032
[TBL] [Abstract][Full Text] [Related]
3. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
[TBL] [Abstract][Full Text] [Related]
4. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
5. Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2).
Szabó K; Nagy Z; Juhász V; Zolnerciks JK; Csorba A; Tímár Z; Molnár É; Pádár P; Johnson W; Beéry E; Krajcsi P
Drug Metab Pharmacokinet; 2017 Jun; 32(3):165-171. PubMed ID: 28365301
[TBL] [Abstract][Full Text] [Related]
6. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney.
Tamai I; China K; Sai Y; Kobayashi D; Nezu J; Kawahara E; Tsuji A
Biochim Biophys Acta; 2001 Jun; 1512(2):273-84. PubMed ID: 11406104
[TBL] [Abstract][Full Text] [Related]
7. Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5).
Visentin M; Gai Z; Torozi A; Hiller C; Kullak-Ublick GA
Drug Metab Dispos; 2017 Dec; 45(12):1240-1244. PubMed ID: 28986476
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
9. SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer.
Juraszek B; Nałęcz KA
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861504
[TBL] [Abstract][Full Text] [Related]
10. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A
Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783
[TBL] [Abstract][Full Text] [Related]
11. Maternal Plasma l-Carnitine Reduction During Pregnancy Is Mainly Attributed to OCTN2-Mediated Placental Uptake and Does Not Result in Maternal Hepatic Fatty Acid
Bai M; Zeng Q; Chen Y; Chen M; Li P; Ma Z; Sun D; Zhou H; Zheng C; Zeng S; Jiang H
Drug Metab Dispos; 2019 Jun; 47(6):582-591. PubMed ID: 30918014
[TBL] [Abstract][Full Text] [Related]
12. Combination of l-Carnitine with Lipophilic Linkage-Donating Gemcitabine Derivatives as Intestinal Novel Organic Cation Transporter 2-Targeting Oral Prodrugs.
Wang G; Chen H; Zhao D; Ding D; Sun M; Kou L; Luo C; Zhang D; Yi X; Dong J; Wang J; Liu X; He Z; Sun J
J Med Chem; 2017 Mar; 60(6):2552-2561. PubMed ID: 28234466
[TBL] [Abstract][Full Text] [Related]
13. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2).
Zhang L; Gui T; Console L; Scalise M; Indiveri C; Hausler S; Kullak-Ublick GA; Gai Z; Visentin M
J Biol Chem; 2021; 296():100204. PubMed ID: 33334877
[TBL] [Abstract][Full Text] [Related]
15. Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+).
Srinivas SR; Prasad PD; Umapathy NS; Ganapathy V; Shekhawat PS
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1046-53. PubMed ID: 17855766
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Okura T; Kato S; Deguchi Y
Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
[TBL] [Abstract][Full Text] [Related]
17. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
[TBL] [Abstract][Full Text] [Related]
18. The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase.
Papierniak-Wyglądała A; Lamch W; Jurewicz E; Nałęcz KA
Arch Biochem Biophys; 2023 Jul; 742():109616. PubMed ID: 37187422
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes.
Czeredys M; Samluk Ł; Michalec K; Tułodziecka K; Skowronek K; Nałęcz KA
PLoS One; 2013; 8(12):e82105. PubMed ID: 24349196
[TBL] [Abstract][Full Text] [Related]
20. The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate.
Grigat S; Fork C; Bach M; Golz S; Geerts A; Schömig E; Gründemann D
Drug Metab Dispos; 2009 Feb; 37(2):330-7. PubMed ID: 18981167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
